In focus · trending topic

mass cytometry

10 stories · following the connections

Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research

By Nasdaq OMXApr 13, 2018, 8:10 PM UTC

Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis

By Nasdaq OMXOct 24, 2017, 12:10 PM UTC

European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research

By Nasdaq OMXMay 4, 2017, 8:11 PM UTC

European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research

By Nasdaq OMXMay 4, 2017, 8:11 PM UTC

Fluidigm Announces First Quarter Financial Results

By Nasdaq OMXMay 4, 2017, 8:07 PM UTC

Fluidigm Announces First Quarter Financial Results

By Nasdaq OMXMay 4, 2017, 8:07 PM UTC

Fluidigm Announces First Quarter Financial Results

By Nasdaq OMXMay 4, 2017, 8:07 PM UTC

Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors

By Nasdaq OMXMar 27, 2017, 8:05 PM UTC